Peter Dominiak Selected Research

Angiotensin II Type 1 Receptor Blockers

6/2005

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Dominiak Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2010 - 01/2003
5	Infarction (Infarctions) 04/2008 - 09/2002
4	Ischemia 11/2006 - 09/2002
3	Myocardial Infarction 11/2006 - 09/2002
2	Obesity 01/2010 - 09/2007
2	Insulin Resistance 01/2010 - 09/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2006 - 07/2003
2	Stroke (Strokes) 06/2005 - 07/2003
2	Ganglion Cysts (Ganglion) 04/2005 - 08/2002
2	Hypoxia (Hypoxemia) 01/2005 - 08/2003
2	Reperfusion Injury 09/2004 - 09/2002
1	Endotoxemia 01/2016
1	Cough 07/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2007
1	Body Weight (Weight, Body) 11/2006
1	Coronary Occlusion 11/2006
1	Diabetes Mellitus 03/2006
1	Proteinuria 03/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2004
1	Myocardial Reperfusion Injury 09/2004
1	Necrosis 09/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2004
1	Diabetes Complications 04/2003
1	Hypersensitivity (Allergy) 03/2003
1	Hypertrophy 12/2002

Drug/Important Bio-Agent (IBA)

5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2008 - 12/2002
4	Messenger RNA (mRNA)IBA 08/2005 - 04/2003
3	LeptinIBA 01/2010 - 11/2006
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2006 - 09/2002
3	Proteins (Proteins, Gene)FDA Link 03/2006 - 08/2003
2	Ramipril (Altace)FDA LinkGeneric 07/2008 - 03/2006
2	Glucose (Dextrose)FDA LinkGeneric 09/2007 - 11/2006
2	Angiotensin IIIBA 10/2005 - 09/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2005 - 09/2003
2	Hexamethonium (Hexamethonium Bromide)IBA 04/2005 - 08/2002
2	Phosphotransferases (Kinase)IBA 09/2004 - 09/2002
2	AngiotensinsIBA 07/2003 - 04/2003
2	Endothelin-1 (Endothelin 1)IBA 12/2002 - 09/2002
1	KininsIBA 01/2016
1	triphenyltetrazoliumIBA 04/2008
1	Desipramine (Pertofrane)FDA LinkGeneric 11/2006
1	Insulin (Novolin)FDA Link 11/2006
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 11/2006
1	AlbuminsIBA 03/2006
1	Antihypertensive Agents (Antihypertensives)IBA 03/2006
1	Protein Isoforms (Isoforms)IBA 08/2005
1	CalciumIBA 06/2005
1	NitrendipineIBA 06/2005
1	eprosartan (Teveten)FDA Link 06/2005
1	Angiotensin II Type 1 Receptor BlockersIBA 06/2005
1	calcitonin gene-related peptide (8-37)IBA 04/2005
1	chelerythrineIBA 04/2005
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2005
1	Transcription Factors (Transcription Factor)IBA 01/2005
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2005
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2005
1	IronIBA 01/2005
1	rho-Associated KinasesIBA 10/2004
1	fasudil (AT 877)IBA 10/2004
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2004
1	WortmanninIBA 09/2004
1	Simvastatin (Zocor)FDA LinkGeneric 09/2004
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2004
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2003
1	Erythropoietin FDA Link 08/2003
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2003
1	candesartan cilexetil (Amias)FDA Link 07/2003
1	ReninIBA 04/2003
1	BradykininIBA 03/2003
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2002
1	Trinitrotoluene (TNT)IBA 09/2002
1	Troponin T (Troponin T1)IBA 09/2002
1	Vasoconstrictor AgentsIBA 09/2002
1	IsoenzymesIBA 09/2002
1	Vasopressins (Vasopressin)IBA 09/2002
1	icatibantIBA 08/2002

Therapy/Procedure

2	Therapeutics 07/2003 - 01/2003
1	Secondary Prevention 06/2005
1	Percutaneous Coronary Intervention 09/2002